155 related articles for article (PubMed ID: 18600380)
1. Adverse outcomes associated with noncompliance with melanoma treatment guidelines.
Erickson Foster J; Velasco JM; Hieken TJ
Ann Surg Oncol; 2008 Sep; 15(9):2395-402. PubMed ID: 18600380
[TBL] [Abstract][Full Text] [Related]
2. Compliance with melanoma treatment guidelines in a community teaching hospital: time trends and other variables.
Erickson JL; Velasco JM; Hieken TJ
Ann Surg Oncol; 2008 Apr; 15(4):1211-7. PubMed ID: 18239975
[TBL] [Abstract][Full Text] [Related]
3. Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy.
Cormier JN; Xing Y; Ding M; Lee JE; Mansfield PF; Gershenwald JE; Ross MI; Du XL
J Clin Oncol; 2005 Sep; 23(25):6054-62. PubMed ID: 16135473
[TBL] [Abstract][Full Text] [Related]
4. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.
Nowecki ZI; Rutkowski P; Kulik J; Siedlecki JA; Ruka W
Br J Dermatol; 2008 Sep; 159(3):597-605. PubMed ID: 18616789
[TBL] [Abstract][Full Text] [Related]
5. Health care system and socioeconomic factors associated with variance in use of sentinel lymph node biopsy for melanoma in the United States.
Bilimoria KY; Balch CM; Wayne JD; Chang DC; Palis BE; Dy SM; Lange JR
J Clin Oncol; 2009 Apr; 27(11):1857-63. PubMed ID: 19273706
[TBL] [Abstract][Full Text] [Related]
6. [Melanoma of the skin: excision policy and pathology report writing in the 'Integraal Kankercentrum Zuid' region is in accordance with the guideline in slightly more than half of the patients].
Claassen AT; van Berlo CL; Coebergh JW
Ned Tijdschr Geneeskd; 2001 Oct; 145(43):2079-83. PubMed ID: 11715595
[TBL] [Abstract][Full Text] [Related]
7. [Surgical technique and postoperative morbidity following radical inguinal/iliacal lymph node dissection--a prospective study in 67 patients with malignant melanoma metastatic to the groin].
Mall JW; Reetz C; Koplin G; Schäfer-Hesterberg G; Voit C; Neuss H
Zentralbl Chir; 2009 Sep; 134(5):437-42. PubMed ID: 19757344
[TBL] [Abstract][Full Text] [Related]
8. Clinical risk factors and prognostic significance of local recurrence in cutaneous melanoma.
Moehrle M; Kraemer A; Schippert W; Garbe C; Rassner G; Breuninger H
Br J Dermatol; 2004 Aug; 151(2):397-406. PubMed ID: 15327547
[TBL] [Abstract][Full Text] [Related]
9. [Improved compliance with the 'Melanoma' treatment guideline].
Veerbeek L; van de Poll-Franse LV; Bekkenk MW; Bergman W; Hoekstra HJ; Jansen-Landheer ML; Kruit WH; Mooi WJ; de Vries E; van der Rhee HJ
Ned Tijdschr Geneeskd; 2010; 154():A858. PubMed ID: 20170570
[TBL] [Abstract][Full Text] [Related]
10. A breast center review of compliance with National Comprehensive Cancer Network Breast Cancer guidelines.
Landercasper J; Dietrich LL; Johnson JM
Am J Surg; 2006 Oct; 192(4):525-7. PubMed ID: 16978966
[TBL] [Abstract][Full Text] [Related]
11. Regional recurrence after negative sentinel lymph node biopsy for melanoma.
Carlson GW; Page AJ; Cohen C; Parker D; Yaar R; Li A; Hestley A; Delman KA; Murray DR
Ann Surg; 2008 Sep; 248(3):378-86. PubMed ID: 18791358
[TBL] [Abstract][Full Text] [Related]
12. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
Mandalà M; Imberti GL; Piazzalunga D; Belfiglio M; Labianca R; Barberis M; Marchesi L; Poletti P; Bonomi L; Novellino L; Di Biagio K; Milesi A; Guerra U; Tondini C
Eur J Cancer; 2009 Sep; 45(14):2537-45. PubMed ID: 19553103
[TBL] [Abstract][Full Text] [Related]
13. Method of detection of initial recurrence of stage II/III cutaneous melanoma: analysis of the utility of follow-up staging.
Meyers MO; Yeh JJ; Frank J; Long P; Deal AM; Amos KD; Ollila DW
Ann Surg Oncol; 2009 Apr; 16(4):941-7. PubMed ID: 19101766
[TBL] [Abstract][Full Text] [Related]
14. [Detection of the first recurrence in patients with melanoma: three quarters by the patient, one quarter during outpatient follow-up].
Francken AB; Thompson JF; Bastiaannet E; Hoekstra HJ
Ned Tijdschr Geneeskd; 2008 Mar; 152(10):557-62. PubMed ID: 18402322
[TBL] [Abstract][Full Text] [Related]
15. Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer.
Nguyen NP; Vos P; Lee H; Borok TL; Karlsson U; Martinez T; Welsh J; Cohen D; Hamilton R; Nguyen N; Nguyen LM; Vinh-Hung V
Oncology; 2008; 75(3-4):186-91. PubMed ID: 18841033
[TBL] [Abstract][Full Text] [Related]
16. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
[TBL] [Abstract][Full Text] [Related]
17. Institutional validation of breast cancer treatment guidelines.
Minter RM; Spengler KK; Topping DP; Flug R; Copeland EM; Lind DS
J Surg Res; 2001 Sep; 100(1):106-9. PubMed ID: 11516212
[TBL] [Abstract][Full Text] [Related]
18. Desmoplastic melanoma: the role of radiotherapy in improving local control.
Foote MC; Burmeister B; Burmeister E; Bayley G; Smithers BM
ANZ J Surg; 2008 Apr; 78(4):273-6. PubMed ID: 18366400
[TBL] [Abstract][Full Text] [Related]
19. Baseline institutional compliance with NCCN guidelines: non-small-cell lung cancer.
Walsh GL; Winn RJ
Oncology (Williston Park); 1997 Nov; 11(11A):161-70. PubMed ID: 9430187
[TBL] [Abstract][Full Text] [Related]
20. [Late recurrence of melanoma beyond 10 years].
Avril MF; Nguyen T; Duvillard P; Bognel C; Margulis A
Ann Dermatol Venereol; 1994; 121(6-7):454-8. PubMed ID: 7702277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
